Business Context and Reporting Period
Insulet Corporation filed a Form 8-K on April 10, 2012, reporting the entry into a Material Definitive Agreement. The filing concerns an amendment to a distribution agreement with Ypsomed Distribution AG regarding the OmniPod Insulin Management System.
Key Financial Metrics
This filing is a current report regarding a contractual agreement and does not contain financial statements. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The primary material change is the execution of Amendment No. 1 to the Original Distribution Agreement dated January 4, 2010. Key modifications include:
- Geographic Expansion: The list of countries where Ypsomed serves as the exclusive distributor was expanded by eleven additional countries.
- Term Extension: The agreement term was extended until June 30, 2016.
- Automatic Renewal: The term may be automatically extended if Ypsomed's annual purchases in 2013 and 2014 exceed specified targets.
- Commercial Terms: The amendment adjusts warranty provisions, minimum purchase requirements, and certain pricing terms.
- Target Adjustments: The parties agreed to negotiate adjustments to minimum purchase targets upon the occurrence of specified events.
Guidance, Outlook, and Risks
Management commentary is limited to the description of the agreement's terms. The filing notes that certain portions of the Amendment have been redacted pending a request for confidential treatment under Rule 24b-2. No specific financial guidance, risk factors, or contingencies beyond the contractual obligations are detailed in this text.
Investor Verification Checklist
- Verify the specific list of eleven additional countries added to the distribution territory.
- Review the specific minimum purchase targets for 2013 and 2014 required for automatic term extension.
- Examine the redacted portions of the Amendment filed under confidential treatment for details on pricing and warranty adjustments.
- Confirm the impact of the expanded distribution on future revenue recognition in the upcoming 10-Q for the quarter ended March 31, 2012.